{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:40:24Z","timestamp":1776908424153,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82503570"],"award-info":[{"award-number":["82503570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172571"],"award-info":[{"award-number":["82172571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M781941"],"award-info":[{"award-number":["2025M781941"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15855-0","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:34:05Z","timestamp":1773668045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulation of natural killer cell infiltration and tumor progression by CMTM6 in gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Fangzhou","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhua","family":"Bei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"15855_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-025-01734-x","volume":"18","author":"L Huang","year":"2025","unstructured":"Huang L, Zhu H, Shi Y. Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000\u20132025). J Hematol Oncol. 2025;18(1):107. https:\/\/doi.org\/10.1186\/s13045-025-01734-x.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"15855_CR2","doi-asserted-by":"publisher","first-page":"100002","DOI":"10.1016\/j.craph.2025.100002","volume":"19","author":"L Lian","year":"2026","unstructured":"Lian L, Han ZX, Jiang N, nan, et al. Stereotactic body radiation therapy enhances therapeutic efficacy of immune checkpoint inhibitors by promoting the releasing of interferon-\u03b3 and interleukin-2. Curr Radiopharmaceuticals. 2026;19(1):100002. https:\/\/doi.org\/10.1016\/j.craph.2025.100002.","journal-title":"Curr Radiopharmaceuticals"},{"issue":"10294","key":"15855_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2.","journal-title":"Lancet"},{"issue":"4","key":"15855_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10120-021-01173-w","volume":"24","author":"N Boku","year":"2021","unstructured":"Boku N, Satoh T, Ryu MH, et al. Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab. Gastric Cancer. 2021;24(4):946\u201358. https:\/\/doi.org\/10.1007\/s10120-021-01173-w.","journal-title":"Gastric Cancer"},{"issue":"8","key":"15855_CR5","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.lddd.2025.100127","volume":"22","author":"L Tao","year":"2025","unstructured":"Tao L, Zeng P, Yuan X, et al. The application of immunoprotein inhibitor treatment regimens based on PD-L1: A retrospective analysis after the progression of advanced gastric cancer. Lett Drug Des Discovery. 2025;22(8):100127. https:\/\/doi.org\/10.1016\/j.lddd.2025.100127.","journal-title":"Lett Drug Des Discovery"},{"issue":"7670","key":"15855_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature23643","volume":"549","author":"ML Burr","year":"2017","unstructured":"Burr ML, Sparbier CE, Chan YC, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017;549(7670):101\u20135. https:\/\/doi.org\/10.1038\/nature23643.","journal-title":"Nature"},{"issue":"7670","key":"15855_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature23669","volume":"549","author":"R Mezzadra","year":"2017","unstructured":"Mezzadra R, Sun C, Jae LT, et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature. 2017;549(7670):106\u201310. https:\/\/doi.org\/10.1038\/nature23669.","journal-title":"Nature"},{"key":"15855_CR8","doi-asserted-by":"publisher","unstructured":"Liu Q, Wang J, Guo Z et al. CMTM6 promotes hepatocellular carcinoma progression through stabilizing \u03b2-catenin. Cancer Letters Dec 2023:216585. https:\/\/doi.org\/10.1016\/j.canlet.2023.216585.","DOI":"10.1016\/j.canlet.2023.216585"},{"issue":"1","key":"15855_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12967-021-02787-5","volume":"19","author":"X Huang","year":"2021","unstructured":"Huang X, Xiang L, Wang B, et al. CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells. J Transl Med. 2021;19(1):120. https:\/\/doi.org\/10.1186\/s12967-021-02787-5.","journal-title":"J Transl Med"},{"key":"15855_CR10","doi-asserted-by":"publisher","unstructured":"Shaha A, Wang Y, Wang X, et al. CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer. Exp Mol Med. 2024. https:\/\/doi.org\/10.1038\/s12276-024-01303-1.","DOI":"10.1038\/s12276-024-01303-1"},{"key":"15855_CR11","doi-asserted-by":"publisher","unstructured":"Wang Z, Peng Z, Liu Q, et al. Co-Expression with Membrane CMTM6\/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1\/L1 Therapeutic Efficacy in Gastric Adenocarcinoma. Cancers (Basel). 2021;13(20). https:\/\/doi.org\/10.3390\/cancers13205175.","DOI":"10.3390\/cancers13205175"},{"key":"15855_CR12","doi-asserted-by":"publisher","unstructured":"Miao B, Hu Z, Mezzadra R, et al. CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1. Cancer Cell September. 2023;S1535610823002842. https:\/\/doi.org\/10.1016\/j.ccell.2023.08.008.","DOI":"10.1016\/j.ccell.2023.08.008"},{"key":"15855_CR13","doi-asserted-by":"publisher","first-page":"106478","DOI":"10.1016\/j.intimp.2020.106478","volume":"83","author":"H Wang","year":"2020","unstructured":"Wang H, Gao J, Zhang R, Li M, Peng Z, Wang H. Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression. Int Immunopharmacol. 2020;83:106478. https:\/\/doi.org\/10.1016\/j.intimp.2020.106478.","journal-title":"Int Immunopharmacol"},{"issue":"15","key":"15855_CR14","doi-asserted-by":"publisher","first-page":"eaao6869","DOI":"10.1126\/sciimmunol.aao6869","volume":"2","author":"GK Griffin","year":"2017","unstructured":"Griffin GK. A recycling program that keeps PD-L1 out of the cancer cell\u2019s junkyard. Sci Immunol. 2017;2(15):eaao6869. https:\/\/doi.org\/10.1126\/sciimmunol.aao6869.","journal-title":"Sci Immunol"},{"issue":"1","key":"15855_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Sig Transduct Target Ther. 2025;10(1):227. https:\/\/doi.org\/10.1038\/s41392-025-02280-1.","journal-title":"Sig Transduct Target Ther"},{"key":"15855_CR16","doi-asserted-by":"publisher","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.636568.","DOI":"10.3389\/fimmu.2021.636568"},{"issue":"2","key":"15855_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2023;23(2):90\u2013105. https:\/\/doi.org\/10.1038\/s41577-022-00732-1.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"15855_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","volume":"15","author":"L Co\u00ebnon","year":"2024","unstructured":"Co\u00ebnon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M. Natural Killer cells at the frontline in the fight against cancer. Cell Death Dis. 2024;15(8):614. https:\/\/doi.org\/10.1038\/s41419-024-06976-0.","journal-title":"Cell Death Dis"},{"issue":"8","key":"15855_CR19","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1158\/0008-5472.CAN-11-3208","volume":"72","author":"RB Liu","year":"2012","unstructured":"Liu RB, Engels B, Arina A, et al. Densely Granulated Murine NK Cells Eradicate Large Solid Tumors. Cancer Res. 2012;72(8):1964\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3208.","journal-title":"Cancer Res"},{"issue":"5","key":"15855_CR20","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.13569","volume":"109","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Nomura S, Hosoi A, et al. Established gastric cancer cell lines transplantable into C57BL\/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth. Cancer Sci. 2018;109(5):1480\u201392. https:\/\/doi.org\/10.1111\/cas.13569.","journal-title":"Cancer Sci"},{"issue":"5","key":"15855_CR21","doi-asserted-by":"publisher","first-page":"106724","DOI":"10.1016\/j.isci.2023.106724","volume":"26","author":"D Siegl","year":"2023","unstructured":"Siegl D, Kruchem M, Jansky S, et al. A PCR protocol to establish standards for routine mycoplasma testing that by design detects over 90% of all known mycoplasma species. iScience. 2023;26(5):106724. https:\/\/doi.org\/10.1016\/j.isci.2023.106724.","journal-title":"iScience"},{"key":"15855_CR22","unstructured":"Leary S, Pharmaceuticals F, Underwood W et al. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. Am Veterinary Med Association. 2020."},{"issue":"8","key":"15855_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi H, Muruganujan A, Casagrande JT, Thomas PD. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013;8(8):1551\u201366. https:\/\/doi.org\/10.1038\/nprot.2013.092.","journal-title":"Nat Protoc"},{"issue":"6340","key":"15855_CR24","doi-asserted-by":"publisher","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","volume":"356","author":"PJ Thul","year":"2017","unstructured":"Thul PJ, \u00c5kesson L, Wiking M, et al. A subcellular map of the human proteome. Science. 2017;356(6340):eaal3321. https:\/\/doi.org\/10.1126\/science.aal3321.","journal-title":"Science"},{"key":"15855_CR25","volume-title":"WHO Classification of Tumours: Digestive System Tumours","author":"World Health Organization Classification of Tumours Editorial Board, ed","year":"2019","unstructured":"World Health Organization Classification of Tumours Editorial Board, ed. WHO Classification of Tumours: Digestive System Tumours. 5th ed. Lyon: International agency for research on cancer; 2019.","edition":"5"},{"issue":"37","key":"15855_CR26","doi-asserted-by":"publisher","first-page":"14836","DOI":"10.1073\/pnas.1212912109","volume":"109","author":"D Samanta","year":"2012","unstructured":"Samanta D, Ramagopal UA, Rubinstein R, Vigdorovich V, Nathenson SG, Almo SC. Structure of Nectin-2 reveals determinants of homophilic and heterophilic interactions that control cell-cell adhesion. Proc Natl Acad Sci U S A. 2012;109(37):14836\u201340. https:\/\/doi.org\/10.1073\/pnas.1212912109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"15855_CR27","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1016\/j.febslet.2006.08.053","volume":"580","author":"T Proikas-Cezanne","year":"2006","unstructured":"Proikas-Cezanne T, Gaugel A, Frickey T, Nordheim A. Rab14 is part of the early endosomal clathrin-coated TGN microdomain. FEBS Lett. 2006;580(22):5241\u20136. https:\/\/doi.org\/10.1016\/j.febslet.2006.08.053.","journal-title":"FEBS Lett"},{"issue":"5","key":"15855_CR28","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.devcel.2012.04.010","volume":"22","author":"A Linford","year":"2012","unstructured":"Linford A, Yoshimura S, ichiro N, Bastos R, et al. Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction stability in migrating cells. Dev Cell. 2012;22(5):952\u201366. https:\/\/doi.org\/10.1016\/j.devcel.2012.04.010.","journal-title":"Dev Cell"},{"issue":"11","key":"15855_CR29","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1091\/mbc.E13-12-0724","volume":"25","author":"R Lu","year":"2014","unstructured":"Lu R, Johnson DL, Stewart L, Waite K, Elliott D, Wilson JM. Rab14 regulation of claudin-2 trafficking modulates epithelial permeability and lumen morphogenesis. Mol Biol Cell. 2014;25(11):1744\u201354. https:\/\/doi.org\/10.1091\/mbc.E13-12-0724.","journal-title":"Mol Biol Cell"},{"issue":"8","key":"15855_CR30","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1091\/mbc.E14-12-1613","volume":"26","author":"R Lu","year":"2015","unstructured":"Lu R, Dalgalan D, Mandell EK, Parker SS, Ghosh S, Wilson JM. PKC\u03b9 interacts with Rab14 and modulates epithelial barrier function through regulation of claudin-2 levels. Mol Biol Cell. 2015;26(8):1523\u201331. https:\/\/doi.org\/10.1091\/mbc.E14-12-1613.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"15855_CR31","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1091\/mbc.e03-10-0777","volume":"15","author":"JR Junutula","year":"2004","unstructured":"Junutula JR, De Mazi\u00e9re AM, Peden AA, et al. Rab14 is involved in membrane trafficking between the Golgi complex and endosomes. Mol Biol Cell. 2004;15(5):2218\u201329. https:\/\/doi.org\/10.1091\/mbc.e03-10-0777.","journal-title":"Mol Biol Cell"},{"issue":"4","key":"15855_CR32","doi-asserted-by":"publisher","first-page":"e006401","DOI":"10.1136\/jitc-2022-006401","volume":"11","author":"MM Melssen","year":"2023","unstructured":"Melssen MM, Sheybani ND, Leick KM, Slingluff CL. Barriers to immune cell infiltration in tumors. J Immunother Cancer. 2023;11(4):e006401. https:\/\/doi.org\/10.1136\/jitc-2022-006401.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"15855_CR33","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.7150\/thno.58390","volume":"11","author":"YT Liu","year":"2021","unstructured":"Liu YT, Sun ZJ. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics. 2021;11(11):5365\u201386. https:\/\/doi.org\/10.7150\/thno.58390.","journal-title":"Theranostics"},{"issue":"2","key":"15855_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/0115701646302487240524103934","volume":"21","author":"V Dayhimi","year":"2024","unstructured":"Dayhimi V, Ziadlou F, Nafian S, Nafian F. An Immunoinformatic Approach to Designing a Multi-epitope Vaccine against Helicobacter pylori with the VacA Toxin and BabA Adhesion. Curr Proteomics. 2024;21(2):97\u2013112. https:\/\/doi.org\/10.2174\/0115701646302487240524103934.","journal-title":"Curr Proteomics"},{"issue":"1","key":"15855_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12998\/wjcc.v5.i1.1","volume":"5","author":"K Kai","year":"2017","unstructured":"Kai K, Masuda M, Aishima S. Inverse correlation between CD8\u2009+\u2009inflammatory cells and E-cadherin expression in gallbladder cancer: Tissue microarray and imaging analysis. World J Clin Cases. 2017;5(1):1\u20138. https:\/\/doi.org\/10.12998\/wjcc.v5.i1.1.","journal-title":"World J Clin Cases"},{"issue":"12","key":"15855_CR36","doi-asserted-by":"publisher","first-page":"e1240857","DOI":"10.1080\/2162402X.2016.1240857","volume":"5","author":"EP Salerno","year":"2016","unstructured":"Salerno EP, Bedognetti D, Mauldin IS, et al. Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk. OncoImmunology. 2016;5(12):e1240857. https:\/\/doi.org\/10.1080\/2162402X.2016.1240857.","journal-title":"OncoImmunology"},{"issue":"2","key":"15855_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccell.2023.12.008","volume":"42","author":"J Wienke","year":"2024","unstructured":"Wienke J, Visser LL, Kholosy WM, et al. Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy. Cancer Cell. 2024;42(2):283\u2013e3008. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.008.","journal-title":"Cancer Cell"},{"issue":"42","key":"15855_CR38","doi-asserted-by":"publisher","first-page":"17858","DOI":"10.1073\/pnas.0903474106","volume":"106","author":"N Stanietsky","year":"2009","unstructured":"Stanietsky N, Simic H, Arapovic J, et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci. 2009;106(42):17858\u201363. https:\/\/doi.org\/10.1073\/pnas.0903474106.","journal-title":"Proc Natl Acad Sci"},{"issue":"27","key":"15855_CR39","doi-asserted-by":"publisher","first-page":"11413","DOI":"10.1074\/jbc.M117.786483","volume":"292","author":"FA Deuss","year":"2017","unstructured":"Deuss FA, Gully BS, Rossjohn J, Berry R. Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT). J Biol Chem. 2017;292(27):11413\u201322. https:\/\/doi.org\/10.1074\/jbc.M117.786483.","journal-title":"J Biol Chem"},{"issue":"6","key":"15855_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/eji.201847848","volume":"49","author":"R Molfetta","year":"2019","unstructured":"Molfetta R, Milito ND, Zitti B, et al. The Ubiquitin-proteasome pathway regulates Nectin2\/CD112 expression and impairs NK cell recognition and killing. Eur J Immunol. 2019;49(6):873\u201383. https:\/\/doi.org\/10.1002\/eji.201847848.","journal-title":"Eur J Immunol"},{"issue":"3","key":"15855_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41419-022-04676-1","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Zhu Y, Yang J, et al. CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma. Cell Death Dis. 2022;13(3):251. https:\/\/doi.org\/10.1038\/s41419-022-04676-1.","journal-title":"Cell Death Dis"},{"issue":"1","key":"15855_CR42","doi-asserted-by":"publisher","first-page":"2011673","DOI":"10.1080\/2162402X.2021.2011673","volume":"11","author":"H Wang","year":"2022","unstructured":"Wang H, Fan Y, Chen W, et al. Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity. Oncoimmunology. 2022;11(1):2011673. https:\/\/doi.org\/10.1080\/2162402X.2021.2011673.","journal-title":"Oncoimmunology"},{"issue":"10","key":"15855_CR43","doi-asserted-by":"publisher","first-page":"e1000676","DOI":"10.1371\/journal.pgen.1000676","volume":"5","author":"CH Ooi","year":"2009","unstructured":"Ooi CH, Ivanova T, Wu J, et al. Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer. PLoS Genet. 2009;5(10):e1000676. https:\/\/doi.org\/10.1371\/journal.pgen.1000676.","journal-title":"PLoS Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15855-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15855-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15855-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:51:30Z","timestamp":1776905490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15855-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15855"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15855-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and manipulations were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and the study protocol was reviewed and approved by the Minhang Hospital Ethics Committee (Approval No: 249). All research procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"515"}}